Please join us for a 60-minute online panel co-hosted by Crystal Pharmatech and Cypin Production on “8 Tips to Alleviate IP Concerns Around China Pharma Products”.
China offers invaluable business and growth opportunities and has become an important market for many US companies. However, concerns about intellectual property (IP) protection remain high. This webinar will explore common IP concerns around trade- and contract-related issues. You will leave the session with tips and strategies to effectively protect your Pharma products in China.
This is a 60-minute moderator-led panel in Q&A format to explore and provide solutions to the following concerns:
Concern 1: China IP laws expressly favor domestic interests
Concern 2: Chinese companies do not respect IP
Concern 3: Chinese laws does not govern theft of third party IP
Concern 4: Trade-secret thefts are common in China
Concern 5: Chinese companies bear no liability in case IP or confidentiality is breached
Concern 6: Enforcing intellectual property rights (IPR) is very difficult in China
Concern 7: Foreign companies cannot control the future of invention discovered in China
Concern 8: Dispute resolution in China-which law to govern? US or China?
- Robert Wenslow, Vice President of Business Development, Crystal Pharmatech
- Benjamin Liu, J.D., Assistant Professor, China IP Resource Center, John Marshall Law School
- Jiwen Chen, Attorney-at-law/Asia Practice Director, Jacobson Holman PLLC